Candel Therapeutics

CADL · NASDAQ

$8.64+$0.43 (+5.24%)TodayMarket closed ·
Prev close $8.21

Who owns CADL

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 28.8% of CADL’s shares.

  • PBM Capital Group, LLC9.3%
  • Aguilar-Cordova (Estuardo)4.2%
  • Manning (Paul B.)3.2%
  • Fidelity Management & Research Company LLC3.1%
  • Next 6 largest institutions9.1%
  • All other shareholders71.2%
Top institutional holders of CADL
HolderShares% of shares
PBM Capital Group, LLC6.78M9.25%
Aguilar-Cordova (Estuardo)3.09M4.22%
Manning (Paul B.)2.32M3.17%
Fidelity Management & Research Company LLC2.26M3.09%
Northpond Ventures, LLC1.94M2.64%
Franklin Advisers, Inc.1.13M1.54%
EAC Descendants Irrevocable Trust942.34K1.29%
LKA Descendants Irrevocable Trust942.34K1.29%
Aguilar (Laura K)874.94K1.19%
Sands Capital Ventures LLC811.74K1.11%

Largest mutual fund holders

Top mutual fund holders of CADL
HolderShares% of shares
Fidelity Select Biotechnology Portfolio2.26M3.09%
Franklin Templeton Investment Funds -Biotechnology Discovery724.20K0.99%
Franklin Biotechnology Discovery Fund400.80K0.55%
Vanguard Total Stock Market Index Fund269.90K0.37%
Vanguard Extended Market Index Fund133.88K0.18%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $3.55M (5 trades) of CADL on the open market, with no buys.

Latest CADL insider transactions
InsiderTypeSharesValue
Loggia NicolettaAward380$3.30K
Manning Paul BAward2.19K$18.99K
PAPA JOSEPH CAward1.32K$11.50K
Tak Paul PeterSale59.38K$620.89K
Tak Paul PeterOption exercise125.00K—
Tak Paul PeterSale220.87K$2.54M
Tak Paul PeterOption exercise125.00K$193.75K
Zimmermann MartineAward64.00K—
Tyagarajan SeshuSale7.00K$84.00K
Sims Mark E.Award285.00K—

Short interest

Settled Sep 30, 2026

Shares short
13.00M
Days to cover
11.15
% of shares outstanding
17.74%
Average daily volume
1.17M
Change since last report
+5.3%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.